Molbio Diagnostics IPO

Molbio Diagnostics IPO is a book-built issue worth Rs 939.70 crores, comprising a fresh issue of Rs 200.00 crores and an Offer for Sale of Rs 739.70 crores. The IPO opened for subscription on August 10, 2026, and will close on August 12, 2026, with allotment expected on August 13, 2026. The shares are scheduled to list on NSE and BSE on August 17, 2026. The price band is fixed at Rs 768-807 per share, with a lot size of 18 shares requiring a minimum retail investment of Rs 14,526. The issue also reserves 20,520 shares for employees at a Rs 76 discount. Kotak Mahindra Capital is the lead manager, while Kfin Technologies is the registrar.

Apply For IPO

Molbio Diagnostics IPO Details

Check out the issue details for Molbio Diagnostics IPO as disclosed in SEBI.

Price Band

₹ 768 - 807

Issue Size

940.00 Cr.

Issue Type

Book Built

Open

2026-08-10

Close

2026-08-12

Listing Date

2026-08-17

Company Financials

You can get the following financial statements of Molbio Diagnostics as of now.

Molbio Diagnostics IPO Details

The details about the Molbio Diagnostics IPO are as follows:

  • The issue size of the IPO is Rs 939.70 Cr.
  • The price band for Molbio Diagnostics IPO is Rs 768 to Rs 807.
  • The shares of Molbio Diagnostics IPO will list on BSE and NSE.
  • The latest tentative GMP of Molbio Diagnostics IPO is Rs 127.
  • The shares of Molbio Diagnostics IPO are subscribed 2.95 Times.

 

Molbio Diagnostics IPO Valuation

The approximate valuation of Molbio Diagnostics IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 807
Existing Shares (Qty) 11.27 Cr
Fresh Issue Rs 200 Cr
Market Cap Rs 9294.89 Cr
EPS (FY26) Rs 14.77
PE Ratio 54.63x
Industry PE 64.89x

 

Molbio Diagnostics IPO Issue Size

Molbio Diagnostics IPO issue size is Rs 939.70 Cr.

Issue Amount
Fresh Issue Rs 200.00 Cr
Offer For Sale Rs 739.70 Cr

 

Molbio Diagnostics IPO Market Lot

An individual can apply for a minimum of 1 lot of 18 shares and a maximum of 13 lots (234 shares). Find the details below:

Application Lot Shares Amount
Retail Minimum 1 18 Rs 14,526
Retail Maximum 13 234 Rs 1,88,838

 

Molbio Diagnostics IPO Share Offer

The shares of Molbio Diagnostics IPO are subscribed 2.95 Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Not more than 50%
Non-Institutional Not less than 15%
Retail Individual Not less than 35%

 

Molbio Diagnostics IPO GMP (Grey Market Premium)

As on GMP (Tentative)
11 August 2026 Rs 127

Molbio Diagnostics IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Molbio Diagnostics IPO Dates

Find below the dates for Molbio Diagnostics IPO

Schedule Date
Basis of Allotment 13 Aug 2026
Refunds 14 Aug 2026
Credit to Demat Account 14 Aug 2026
IPO Listing Date 17 Aug 2026

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 326.57 756.32 971.23
Total Expenditure 286.49 552.62 745.6
Operating Profit 40.09 203.69 225.64
Other Income 8.1 6.52 6.37
Interest 5.94 7.61 8.86
Depreciation 19.39 23.6 26.31
Exceptional Items 0 -27.12 -8.8
Profit Before Tax 22.86 151.89 188.04
Provision for Tax 7.31 40.78 48.22
Net Profit 15.55 111.11 139.82
Adjusted EPS (Rs.) 0.14 0.99 1.24

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 2.25 2.25 2.26
Total Reserves 736.72 847.73 987.82
Borrowings 0.99 15.12 6.14
Other N/C liabilities -4.2 -20.95 -33.92
Current liabilities 177.6 209.81 303.94
Total Liabilities 913.35 1053.97 1266.24
Assets
Net Block 189.31 175.93 214.92
Capital WIP 0 1.58 17.6
Intangible WIP 0 0 0
Investments 53.79 53.79 95.35
Loans & Advances 32.76 50.38 99.85
Other N/C Assets 26.73 48.77 11.99
Current Assets 610.76 723.52 826.53
Total Assets 913.35 1053.97 1266.24
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Profit from operations 22.86 151.89 188.04
Adjustment 19.55 85.62 58.76
Changes in Assets & Liabilities 58.28 -157.07 66.35
Tax Paid -32.79 -42.7 -64.57
Operating Cash Flow 67.9 37.74 248.58
Investing Cash Flow -51.01 -31.44 -97.9
Financing Cash Flow 30.96 -24.2 -17.35
Net Cash Flow 47.84 -17.91 133.33
X